Stress, Emotion Regulation, and Alcohol in Women Veterans
NCT ID: NCT04393623
Last Updated: 2024-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2020-11-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Couple-Based Treatment for Alcohol Use Disorders and Post-Traumatic Stress Disorder
NCT00946322
Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT
NCT01678196
Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)
NCT03929939
Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use
NCT01710943
Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance
NCT00760994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed study will combine experimental, in-person sessions with daily self-report data from the Veterans to assess the effect of cognitive reappraisal on alcohol craving, cognitive (inhibitory) control, physiological arousal (HRV), and alcohol use. Participation will take place across a period of at least 35 days, to encompass an entire menstrual cycle. All participants complete all sections of the study - the experimental sessions and the longitudinal (35-day) data collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Reappraisal Microintervention
The CR microintervention (session 1) is drawn from Barlow \& colleagues empirically supported treatment for emotional disorders (the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders). The microintervention consist of four sections: (1) Introduction to cognitive appraisal; (2) Introducing the idea of "thinking traps" that prevent reappraisal and maintain negative emotion; (3) Describing cognitive reappraisal as a strategy that can help the participant "get out" of such thinking traps; (4) Providing an example of this process (situation\> negative appraisal \> negative emotion \> thinking trap \> opportunity for cognitive reappraisal) and have participants provide a personalized example.
Cognitive Reappraisal
This cognitive reappraisal microintervention lasts 45-60 minutes.
Psychoeducation (Control)
The manualized psychoeducational control module, serving as an attentional control, is derived from two sources: 1. The first session of the Women's Health Education Manual, which provides psychoeducation about the basic body systems and their function, with focus on components of the immune system and 2. Fact sheets published by the American College of Obstetricians and Gynecologists(ACOG), providing female-specific facts about cancer and heart health. None of this psychoeducation discusses potential relevancy of alcohol use, nor will any behavior changes be suggested during the control microintervention.
Psychoeducation
This psychoeducational microintervention lasts 45-60 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Reappraisal
This cognitive reappraisal microintervention lasts 45-60 minutes.
Psychoeducation
This psychoeducational microintervention lasts 45-60 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* If using other illicit substances, alcohol is their primary substance of use
* Alcohol use in the past 45 days
* Able to write and speak in English
* Served in the U.S. Military
* Willing to provide blood samples at laboratory sessions to assay hormone levels and take urine ovulation tests at home
Exclusion Criteria
* Brain damage or were in an accident that affects ability to complete the computerized task
* Current (past 3 months) active suicidal ideation or intent
* Current pregnancy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cathryn Glanton Holzhauer, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Central Western Massachusetts Healthcare System, Leeds, MA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Central Western Massachusetts Healthcare System, Leeds, MA
Leeds, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DVA/CSR&D CDA-2 CX001951
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
MHBB-017-18F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.